Immune checkpoint inhibitors in head and neck squamous cell carcinoma: A systematic review of phase-3 clinical trials

By Jissy Vijo Poulose, C. Kainickal. 2022

Subfields: Immunology, Oncology, Otorhinolaryngology

Citations in the corpus

• Impact of T Cell Exhaustion and Stroma Senescence on Tumor Cell Biology and Clinical Outcome of Head and Neck Squamous Cell Carcinomas (2024, unknown): “The limited clinical success of the currently approved immunotherapeutic strategies underscore the need for further research in head and neck cancer immuno-oncology, particularly as HNSCC is among the most immune-infiltrated human cancers [9,10].”